NICE recommends Ofev for the treatment of PF-ILD
The National Institute for Health and Care Excellence (NICE) has recommended Ofev® (nintedanib) for use in England and Wales for the treatment of adult patients...
NHS receives extra £5.4 billion to support COVID-19 response over next...
The Prime Minister and Health and Social Care Secretary Sajid Javid have announced that the NHS will receive an extra £5.4 billion over the...
PM Society Digital Awards Winners 2021
Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
Career close-up: Managing Director, Paul Steckler
Pf talks to Paul Steckler, Managing Director Europe of Canopy Growth Corporation.
Tell us about the roles that led you to Managing Director?
I’ve always had...
Career close-up: Alessandra Dorigo
Pf talks to Alessandra Dorigo, who was recently appointed General Manager UK, Ireland, Baltics and Nordics at Advanced Accelerator Applications (AAA), a Novartis company. Tell...
Succeeding in the digital domain
Pf talks to Heidi Edwards, Senior Respiratory E-detail Representative at Bionical Solutions, on behalf of AstraZeneca and winner of the Digitally Enabled Sales Professional...
Finding a job and recruiting in 2021
PharmaJobs understands the pressure on finding a job and recruiting so it’s making some changes to help recruiters and job seekers in 2021. As we...
Career advice from pharma professionals
In an industry which has excelled in the face of adversity this year, some expert advice can help you do the same in your...
China: making the most of global pharma opportunities
Pharmaceutical organisations in China are increasingly looking overseas due to changes to the country’s domestic market policy and improvements in drug traceability, accountability, quality...
Life sciences industry and the post-Brexit route to market
It is hard to imagine what Brexit might have brought if it weren’t for the pandemic. However, five years on from the UK’s vote...
